BACKGROUND: Patients with venous thromboembolism (VTE) treated with anticoagulants are at risk of death from pulmonary embolism (PE) and/or bleeding. However, whether patients who develop VTE in hospital have a higher complication rate than those who develop VTE in an outpatient setting is unclear. PATIENTS AND METHODS: RIETE is an ongoing, prospective registry of consecutive patients with acute, objectively confirmed, symptomatic VTE. We compared the 3-month incidence of fatal PE and fatal bleeding in patients in whom the VTE had developed while in hospital for another medical condition (inpatients) with those who presented to the emergency ward because of VTE (outpatients). RESULTS: Up to April 2008, 22,133 patients with acute VTE were enrolled: 10,461 (47%) presented with PE, 11,672 with deep vein thrombosis. Overall, 6445 (29%) were inpatients. During the study period, those who developed VTE as inpatients had a significantly higher incidence of fatal PE (2.1% vs. 1.5%; odds ratio: 1.4; 95% CI: 1.1-1.7), overall death (7.0% vs. 5.4%; odds ratio: 1.3; 95% CI: 1.2-1.5), and major bleeding (2.9% vs. 2.1%; odds ratio: 1.4; 95% CI: 1.1-1.6) than outpatients. The incidence of fatal bleeding was not significantly increased (0.7% vs. 0.5%; odds ratio: 1.2; 95% CI: 0.9-1.8). In multivariable analysis, inpatient status was significantly associated with a higher risk for fatal PE (odds ratio: 1.3; 95% CI: 1.1-1.7). CONCLUSIONS: VTE occurring in hospitalized patients carries a significantly higher risk for death of PE than in outpatients, underscoring the importance of VTE prevention strategies in the hospital setting. Copyright (c) 2010 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
BACKGROUND:Patients with venous thromboembolism (VTE) treated with anticoagulants are at risk of death from pulmonary embolism (PE) and/or bleeding. However, whether patients who develop VTE in hospital have a higher complication rate than those who develop VTE in an outpatient setting is unclear. PATIENTS AND METHODS: RIETE is an ongoing, prospective registry of consecutive patients with acute, objectively confirmed, symptomatic VTE. We compared the 3-month incidence of fatal PE and fatal bleeding in patients in whom the VTE had developed while in hospital for another medical condition (inpatients) with those who presented to the emergency ward because of VTE (outpatients). RESULTS: Up to April 2008, 22,133 patients with acute VTE were enrolled: 10,461 (47%) presented with PE, 11,672 with deep vein thrombosis. Overall, 6445 (29%) were inpatients. During the study period, those who developed VTE as inpatients had a significantly higher incidence of fatal PE (2.1% vs. 1.5%; odds ratio: 1.4; 95% CI: 1.1-1.7), overall death (7.0% vs. 5.4%; odds ratio: 1.3; 95% CI: 1.2-1.5), and major bleeding (2.9% vs. 2.1%; odds ratio: 1.4; 95% CI: 1.1-1.6) than outpatients. The incidence of fatal bleeding was not significantly increased (0.7% vs. 0.5%; odds ratio: 1.2; 95% CI: 0.9-1.8). In multivariable analysis, inpatient status was significantly associated with a higher risk for fatal PE (odds ratio: 1.3; 95% CI: 1.1-1.7). CONCLUSIONS:VTE occurring in hospitalized patients carries a significantly higher risk for death of PE than in outpatients, underscoring the importance of VTE prevention strategies in the hospital setting. Copyright (c) 2010 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
Authors: María Lourdes Posadas-Martínez; Fernando Javier Vázquez; María Florencia Grande-Ratti; Fernán González Bernaldo de Quirós; Diego Hernán Giunta Journal: J Thromb Thrombolysis Date: 2015-08 Impact factor: 2.300
Authors: Abdullah Pandor; Daniel Horner; Sarah Davis; Steve Goodacre; John W Stevens; Mark Clowes; Beverley J Hunt; Tim Nokes; Jonathan Keenan; Kerstin de Wit Journal: Health Technol Assess Date: 2019-12 Impact factor: 4.014
Authors: Ava L Liberman; Alexander E Merkler; Gino Gialdini; Steven R Messé; Michael P Lerario; Santosh B Murthy; Hooman Kamel; Babak B Navi Journal: Stroke Date: 2017-02-22 Impact factor: 7.914
Authors: C Rubio-Terrés; J M Soria; P E Morange; J C Souto; P Suchon; J Mateo; N Saut; D Rubio-Rodríguez; J Sala; A Gracia; S Pich; E Salas Journal: Appl Health Econ Health Policy Date: 2015-04 Impact factor: 2.561
Authors: Sonia Jimenez; Pedro Ruiz-Artacho; Marta Merlo; Coral Suero; Albert Antolin; José Ramón Casal; Marta Sanchez; Alejandra Ortega-Duarte; Mar Genis; Pascual Piñera Journal: Medicine (Baltimore) Date: 2017-12 Impact factor: 1.817
Authors: Sònia Jiménez; Òscar Miró; Pere Llorens; Francisco J Martín-Sánchez; Guillermo Burillo-Putze; Pascual Piñera; Alfonso Martín; Aitor Alquézar; Eric J García-Lamberechts; Javier Jacob; María L L Grima; Javier Millán; Francisca Molina; Patricia B Albero; Carlos Cardozo; Josep M Mòdol; Alfons Aguirre; Ruth Gaya; María Adroher; Lluís Llauger; Juan J L Díaz; Nayra C González; Paula L Aragües; Ana P Gómez; Juan G Del Castillo Journal: Eur J Emerg Med Date: 2021-06-01 Impact factor: 4.106